AIRLINK 62.48 Increased By ▲ 2.05 (3.39%)
BOP 5.36 Increased By ▲ 0.01 (0.19%)
CNERGY 4.58 Decreased By ▼ -0.02 (-0.43%)
DFML 15.50 Increased By ▲ 0.66 (4.45%)
DGKC 66.40 Increased By ▲ 1.60 (2.47%)
FCCL 17.59 Increased By ▲ 0.73 (4.33%)
FFBL 27.70 Increased By ▲ 2.95 (11.92%)
FFL 9.27 Increased By ▲ 0.21 (2.32%)
GGL 10.06 Increased By ▲ 0.10 (1%)
HBL 105.70 Increased By ▲ 1.49 (1.43%)
HUBC 122.30 Increased By ▲ 4.78 (4.07%)
HUMNL 6.60 Increased By ▲ 0.06 (0.92%)
KEL 4.50 Decreased By ▼ -0.05 (-1.1%)
KOSM 4.48 Decreased By ▼ -0.09 (-1.97%)
MLCF 36.20 Increased By ▲ 0.79 (2.23%)
OGDC 122.92 Increased By ▲ 0.53 (0.43%)
PAEL 23.00 Increased By ▲ 1.09 (4.97%)
PIAA 29.34 Increased By ▲ 2.05 (7.51%)
PIBTL 5.80 Decreased By ▼ -0.14 (-2.36%)
PPL 107.50 Increased By ▲ 0.13 (0.12%)
PRL 27.25 Increased By ▲ 0.74 (2.79%)
PTC 18.07 Increased By ▲ 1.97 (12.24%)
SEARL 53.00 Decreased By ▼ -0.63 (-1.17%)
SNGP 63.21 Increased By ▲ 2.01 (3.28%)
SSGC 10.80 Increased By ▲ 0.05 (0.47%)
TELE 9.20 Increased By ▲ 0.71 (8.36%)
TPLP 11.44 Increased By ▲ 0.86 (8.13%)
TRG 70.86 Increased By ▲ 0.95 (1.36%)
UNITY 23.62 Increased By ▲ 0.11 (0.47%)
WTL 1.28 No Change ▼ 0.00 (0%)
BR100 6,944 Increased By 65.8 (0.96%)
BR30 22,827 Increased By 258.6 (1.15%)
KSE100 67,142 Increased By 594.3 (0.89%)
KSE30 22,090 Increased By 175.1 (0.8%)

CureVac

European shares slip
Markets

European shares slip

AMSTERDAM/LONDON: European shares fell from record highs on Thursday, tracking declines on Wall Street after the...
Published 18 Jun, 2021 04:16am
CureVac starts review process in Switzerland for COVID-19 vaccine hopeful
World

CureVac starts review process in Switzerland for COVID-19 vaccine hopeful

  • Switzerland, which to date has approved COVID-19 shots from Pfizer, Moderna and Johnson & Johnson, has placed orders for five million doses of CureVac's vaccine. It is a so-called mRNA vaccine, like those from Moderna and Pfizer that are already on the market.
  • "The duration of the rolling review will depend on the completeness of the data submitted by CureVac and the results of the clinical trials, and cannot therefore be predicted," Swissmedic said.
Published 19 Apr, 2021 06:10pm
CureVac says interest in its COVID-19 vaccine on the rise
Business & Finance

CureVac says interest in its COVID-19 vaccine on the rise

  • The European Union in November secured up to 405 million doses of CureVac's two-shot vaccine, which has yet to win regulatory approval, the company's only large supply contract so far.
  • Europe's choppy vaccine rollout hit more trouble this week after J&J suspended shipments of its COVID-19 shot and Denmark said it would drop a similar vaccine from AstraZeneca over very rare cases of blood clotting.
Updated 15 Apr, 2021 07:25pm
EU approves Johnson & Johnson Covid vaccine
World

EU approves Johnson & Johnson Covid vaccine

  • The EU has so far approved three vaccines -- Pfizer-BioNTech, Moderna and AstraZeneca-Oxford. Three other vaccines are under "rolling review" by the Amsterdam-based EMA -- Novavax, CureVac and Russia's Sputnik.
Published 12 Mar, 2021 10:12am
Latest on worldwide spread of the coronavirus
World

Latest on worldwide spread of the coronavirus

  • Portugal's public health system is on the verge of collapsing as hospitals in the areas worst-affected by a worrying surge in coronavirus cases are quickly running out of intensive care beds to treat COVID-19 patients.
Published 18 Jan, 2021 10:26am